Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

161.85
-1.9300-1.18%
Post-market: 162.000.1500+0.09%19:50 EDT
Volume:2.94M
Turnover:477.39M
Market Cap:251.03B
PE:24.23
High:163.90
Open:161.42
Low:160.71
Close:163.78
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.85
T/O Rate:0.20%
Dividend:3.17
Dividend Rate:1.96%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.99
PE(LYR):24.75

Loading ...

Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says

MT Newswires Live
·
12 hours ago

AstraZeneca price target lowered to 150 GBp from 160 GBp at Berenberg

TIPRANKS
·
14 hours ago

Berenberg Trims Price Target on AstraZeneca to $203 From $214, Keeps Buy Rating

MT Newswires Live
·
Yesterday

AstraZeneca's Portfolio Diversity Bodes Well

Dow Jones
·
Yesterday

AstraZeneca (AZN) was upgraded to a Hold Rating at Deutsche Bank

TIPRANKS
·
Yesterday

Berenberg Bank Remains a Buy on AstraZeneca (AZN)

TIPRANKS
·
Yesterday

RBC Capital Sticks to Their Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Yesterday

Top Midday Decliners

MT Newswires Live
·
Yesterday

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Yesterday

AstraZeneca Can Overcome Recent Trial Setbacks

Dow Jones
·
Sep 14

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14

AstraZeneca, Daiichi Drug Has Good Lung-Cancer Data, but Competition Awaits

Dow Jones
·
Sep 14

Sector Update: Healthcare Stocks Rise Premarket Monday

MT Newswires Live
·
Sep 14

AstraZeneca reports results from DESTINY-Lung04 trial

TIPRANKS
·
Sep 14

AstraZeneca reports updated exploratory results from ADAURA trial

TIPRANKS
·
Sep 14

AstraZeneca's Breast Cancer Drug Etcamah Hits A Phase 3 Setback, Clouding Billions In Potential Sales

Options & Short Sell
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Astrazeneca Says Cancer Drugs Enhertu, Tagrisso Show Survival Benefits in Late-Stage Trials

MT Newswires Live
·
Sep 14

AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial

Dow Jones
·
Sep 14

Olema selloff on AstraZeneca miss a buying opportunity, says Citi

TIPRANKS
·
Sep 14